Innovative MedTech Inc. (IMTH)
USD 0.45
(0.0%)
USD 0.45
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 1.87 Million USD | 0.67% |
| 2023 | 2.17 Million USD | -7.05% |
| 2022 | 2.34 Million USD | 4.72% |
| 2021 | 2.23 Million USD | -21.94% |
| 2020 | 2.86 Million USD | 179.37% |
| 2019 | 1.02 Million USD | 0.0% |
| 2014 | 744.96 Thousand USD | 24.57% |
| 2013 | 598.04 Thousand USD | 36.42% |
| 2012 | 438.39 Thousand USD | -46.27% |
| 2011 | 815.99 Thousand USD | -43.9% |
| 2010 | 1.45 Million USD | 280.8% |
| 2009 | 381.93 Thousand USD | -64.22% |
| 2008 | 1.06 Million USD | -29.56% |
| 2007 | 1.51 Million USD | 138.67% |
| 2006 | 635 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.34 Million USD | 7.59% |
| 2024 Q2 | 3.78 Million USD | 61.59% |
| 2024 Q3 | 3.73 Million USD | -1.29% |
| 2024 Q4 | 1.87 Million USD | -41.34% |
| 2023 FY | 2.17 Million USD | -7.05% |
| 2023 Q4 | 2.17 Million USD | -1.02% |
| 2023 Q1 | 2.27 Million USD | -2.86% |
| 2023 Q2 | 2.23 Million USD | -2.01% |
| 2023 Q3 | 2.2 Million USD | -1.36% |
| 2022 Q4 | 2.34 Million USD | 6.52% |
| 2022 FY | 2.34 Million USD | 4.72% |
| 2022 Q3 | 2.2 Million USD | 5.91% |
| 2022 Q2 | 2.07 Million USD | -2.32% |
| 2022 Q1 | 2.12 Million USD | -4.97% |
| 2021 Q3 | 2.26 Million USD | 0.0% |
| 2021 FY | 2.23 Million USD | -21.94% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q4 | 2.23 Million USD | -1.0% |
| 2020 FY | 2.86 Million USD | 179.37% |
| 2019 FY | 1.02 Million USD | 0.0% |
| 2015 Q1 | 744.96 Thousand USD | 14.96% |
| 2014 Q1 | 598.04 Thousand USD | 19.68% |
| 2014 Q2 | 631.9 Thousand USD | 5.66% |
| 2014 Q3 | 636.31 Thousand USD | 0.7% |
| 2014 Q4 | 648.04 Thousand USD | 1.84% |
| 2014 FY | 744.96 Thousand USD | 24.57% |
| 2013 FY | 598.04 Thousand USD | 36.42% |
| 2013 Q2 | 415.4 Thousand USD | -5.25% |
| 2013 Q1 | 438.39 Thousand USD | -39.16% |
| 2013 Q4 | 499.7 Thousand USD | 8.01% |
| 2013 Q3 | 462.64 Thousand USD | 11.37% |
| 2012 Q1 | 815.99 Thousand USD | -2.33% |
| 2012 Q2 | 813.06 Thousand USD | -0.36% |
| 2012 Q3 | 699.46 Thousand USD | -13.97% |
| 2012 Q4 | 720.53 Thousand USD | 3.01% |
| 2012 FY | 438.39 Thousand USD | -46.27% |
| 2011 FY | 815.99 Thousand USD | -43.9% |
| 2011 Q2 | 1.49 Million USD | 2.95% |
| 2011 Q3 | 912.79 Thousand USD | -39.04% |
| 2011 Q4 | 835.43 Thousand USD | -8.48% |
| 2011 Q1 | 1.45 Million USD | 37.13% |
| 2010 FY | 1.45 Million USD | 280.8% |
| 2010 Q2 | 381.93 Thousand USD | 0.0% |
| 2010 Q1 | 381.93 Thousand USD | -59.99% |
| 2010 Q3 | 725.46 Thousand USD | 89.94% |
| 2010 Q4 | 1.06 Million USD | 46.2% |
| 2009 Q3 | 966.34 Thousand USD | -3.42% |
| 2009 FY | 381.93 Thousand USD | -64.22% |
| 2009 Q4 | 954.69 Thousand USD | -1.21% |
| 2009 Q1 | 1.06 Million USD | 15.61% |
| 2009 Q2 | 1 Million USD | -6.27% |
| 2008 Q2 | 1.55 Million USD | 2.45% |
| 2008 Q4 | 923.41 Thousand USD | 2.75% |
| 2008 FY | 1.06 Million USD | -29.56% |
| 2008 Q1 | 1.51 Million USD | 12.65% |
| 2008 Q3 | 898.71 Thousand USD | -42.12% |
| 2007 Q2 | 977.82 Thousand USD | 53.99% |
| 2007 Q3 | 1.11 Million USD | 14.21% |
| 2007 FY | 1.51 Million USD | 138.67% |
| 2007 Q4 | 1.34 Million USD | 20.46% |
| 2007 Q1 | 635 Thousand USD | 20.95% |
| 2006 Q3 | 533.7 Thousand USD | 5.96% |
| 2006 Q2 | 503.7 Thousand USD | 0.0% |
| 2006 Q4 | 525 Thousand USD | -1.63% |
| 2006 FY | 635 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -275.645% |
| Ansell Limited | 855.59 Million USD | 99.78% |
| Ansell Limited | 857.2 Million USD | 99.781% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | 91.619% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -8871.698% |
| Psykey, Inc. | 1.01 Million USD | -85.852% |
| ConvaTec Group Plc | 1.31 Billion USD | 99.857% |
| ConvaTec Group Plc | 1.31 Billion USD | 99.857% |
| Encision Inc. | 1.33 Million USD | -40.881% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 18.646% |
| LifePoint, Inc. | 446.74 Thousand USD | -320.429% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | 65.181% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | 14.197% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -674.066% |
| SmileDirectClub, Inc. | 871.79 Million USD | 99.785% |
| Sector 10, Inc. | 164 Thousand USD | -1045.259% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 99.721% |
| SheerVision, Inc. | 75 Thousand USD | -2404.3% |
| United Health Products, Inc. | 755.98 Thousand USD | -148.446% |
| Vasamed, Inc. | 23.45 Thousand USD | -7909.488% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | 32.13% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -137.6% |